All Infection Prevention & Control articles – Page 4
-
News
Headspace invaders: How mosquito-borne viruses breach the brain’s defenses
Using a stem cell-based model of the human blood-brain barrier, researchers compared two closely related Sindbis virus strains — one brain-invading and one not — and found that small changes in viral surface proteins called glycoproteins dictate whether the virus can cross.
-
News
Okinawan marine sponges yield promising treatment for leishmaniasis
A family of compounds called onnamides shows remarkable potential against the parasite that causes a neglected tropical disease.
-
News
Study models how human behavior, lockdowns and restrictions shaped COVID’s spread
Researchers employed computer modeling and large datasets to better understand how COVID-19 was transmitted in one community in South Africa during the course of the worldwide pandemic.
-
News
New study finds dried blood spot test reliably detects congenital CMV at birth
New research confirms that testing for congenital cytomegalovirus (cCMV) at birth using the routinely collected dried blood spot (DBS) is a reliable and effective method to identify newborns at risk for long-term developmental challenges.
-
News
Study reveals how tick-borne encephalitis virus enters cells
The protein on human cells that tick-borne encephalitis virus (TBEV) uses for infection has now been identified—a major step toward understanding how TBEV causes neurological disease and for developing antiviral drugs.
-
News
Scientists develop a virus cocktail to combat superbugs
Researchers have developed a bespoke phage therapy, Entelli-02, a five-phage cocktail designed specifically to target Enterobacter cloacae complex (ECC), a group of bacteria responsible for severe, often difficult-to-treat infections.
-
News
NIH grant to UC Riverside supports research on dangerous emerging virus
Researchers have been awarded an NIH grant of about $3.4 million over five years to lead an international study focused on developing protective antibodies against Crimean-Congo hemorrhagic fever virus (CCHFV), a biosafety level 4 pathogen and a Category A bioterrorism agent.
-
News
Tropical diseases: Global health meeting showcases resilience of field under fire
At a moment of monumental challenges for global health, thousands of researchers, clinicians and public health professionals from over 100 countries will gather in Toronto for the 2025 Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).
-
News
Next-gen anti-bacterial and anti-viral surface modification technology inspired by Korean mussels
Researchers have successfully developed a next-generation surface modification technology with anti-bacterial and anti-viral contamination properties.While maximizing the bactericidal effect, a polydopamine layer, combined with an antibiotic, inhibits the adsorption of coronavirus.
-
News
Nanoparticles supercharge vinegar’s old-fashioned wound healing power
New research has resulted in the ability to boost the natural bacterial killing qualities of vinegar by adding antimicrobial nanoparticles made from carbon and cobalt.
-
News
Koala stress linked to virus infection risk
Researchers have revealed a clear relationship between stress and increased disease risk in koalas in South East Queensland and on the New South Wales North Coast.The study tracked the level of koala retrovirus (KoRV) in groups of captive and wild koalas.
-
News
Yeast in gut microbiome can worsen salmonella infection
Researchers have discovered that a yeast commonly found in our gut can make infection with salmonella worse. Salmonella binds to Candida albicans and triggers a chain reaction that allows the bacteria to better invade cells lining the intestines.
-
News
Study identifies hotspots of disease-carrying ticks in Illinois
Scientists analyzed the distribution of three potentially harmful tick species in Illinois, identifying regions of the state with higher numbers of these ticks and, therefore, at greater risk of infection with multiple tick-borne diseases.
-
News
‘We need to prepare for a growing number of West Nile virus infections,’ experts warn
Growing numbers of West Nile virus infection cases, fueled by climate change, are sparking fears among healthcare providers in Europe. A clinical insight aims to equip medical professionals with the knowledge needed to recognize and manage this emerging disease.
-
News
Scientists discover powerful new antibiotic class to tackle deadly superbugs
Scientists have discovered Novltex, a new class of antibiotics with potent activity against some of the world’s most dangerous multidrug-resistant (MDR) bacteria. It targets lipid II — an essential building block of bacterial cell walls that does not mutate.
-
News
Guangdong faces largest chikungunya outbreak on record
Guangdong Province is experiencing the largest outbreak of chikungunya fever ever recorded in China, with more than 4,000 confirmed cases since late July. Shunde District of Foshan alone has reported over 3,600 infections, a new paper reports.
-
News
Tuberculosis vulnerability of people with HIV: a viral protein implicated
Tuberculosis accounts for one in three deaths among people living with HIV. A new study highlights the key role played by Tat 2 – a viral protein secreted by HIV-infected cells – in this hyper-vulnerability phenomenon.
-
News
Plant-derived compound has antimicrobial and anti-inflammatory effects against periodontal disease
Morin-based powder, extracted from guava leaves, apple peel, and figs, can be slowly released with the help of polymers and serve as an alternative to antibiotics.
-
News
Gut infections often overlooked in men who have sex with men
It’s time to develop more effective ways to control and prevent sexually transmitted gut infections, urge the authors of an article that discusses discuss several sexually transmitted enteric pathogens that have become extremely multi-drug resistant.
-
News
Major report tackles Covid’s cardiovascular crisis head-on
Regular Covid vaccinations should continue worldwide to reduce cardiac risks associated with the virus - according to new research.